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Abstract
Mycobacterium tuberculosis is the pathogenic bacterial agent commonly
responsible for tuberculosis, or TB. Although treatment exists for the active form of
tuberculosis, no method has been developed for eliminating M tuberculosis in its
dormant state. One hypothesized method for the elimination of dormant TB is to develop
an inhibitor specific for M tuberculosis esterases and lipases, as these esterases and
lipases are essential to the survival of dormant TB infection. In this research, the substrate
specificity of the Rv0045c esterase from M tuberculosis was studied due to the essential
role of Rv0045c in TB metabolism and its dissimilarity to other esterases. Two
fluorogenic substrates, fluorescein dieethylbutyloxymethyl ether) and fluorescein
di(phenylbutyloxymethyl ether), were designed to match the binding pocket structure of
Rv0045c and to test the substrate specificity of the Rv0045c esterase. Both fluorogenic
substrates were synthesized via a three step synthetic process with reasonable yields (1.63%
and 5.6%) and purified using column chromatography. Correct purification of one final
product was confirmed using liquid chromatography mass spectrometry (LCMS) and
HNMR, giving the expected masses and NMR spectrum. This substrate was then tested
for its stability to hydrolyze in water and the kinetics for activation by Rv0045c.
Michaelis-Menten kinetic values were determined for the interaction between the
substrate and both Rv0045c and pig liver esterase (PLE), a common esterase. The
specificity constants for Rv0045c and PLE were 2.95 M-1 S-I and 20.99 M-1 s',
respectively; these results indicate that the synthesized substrate shows no specificity to
Rv0045c and that it would be inappropriate to use for the development of a prodrug
against TB.
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Background and Significance
Tuberculosis and Mycobacterium tuberculosis
Mycobacterium tuberculosis is the pathogenic bacterial agent commonly
responsible for causing tuberculosis (TB). TB is highly contagious and is spread through
droplets either from the throat or lung of an actively infected individual. According to
the World Health Organization (WHO), there were 9.4 million new cases of TB and 1.7
million deaths from the infection in 2010 (WHO 2010). Although a 6-month antibacterial
treatment for TB exists, there are two issues that prevent its elimination: TB primarily
affects those in developing countries with limited access to treatment, and the
antibacterial treatment can only be used once the immune system weakens enough to
allow symptoms to show (Cotes et al., 2008). These limitations demand that other
methods of treatment be pursued.
Interestingly, many patients infected with TB are unaware that it is in their system
because Mycobacterium tuberculosis has the capability of lying dormant within the body
for decades without showing any symptoms in the patient (Cotes et al., 2008). This
dormancy is triggered by the presence of the patient's immune system, and it allows the
pathogen to essentially 'hibernate' until the immune system is weakened and the
opportunity presents itself to attack. Currently, the antibacterial treatment for TB patients
is only effective in killing Mycobacterium tuberculosis when it is in its active state and
may not eliminate all bacterium if there are some that lie dormant during treatment; a
new method of eradicating the pathogen while it lies in its dormant phase is desired in
order to prevent an active TB infection (Cotes et al., 2008).
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One of the ways in which M tuberculosis is able to lie dormant for long periods
of time is through lipid metabolism. Analysis of its genome shows that about 250 genes
are used to code enzymes for this function, whereas Escherichia coli only contains about
50 genes toward lipid metabolism (Cole et al., 1998). These genes are proposed to code
for lipid metabolism enzymes that are used both intracellularly to release stored energy
from lipids and fatty acids and extracellularly to breakdown the membranes on host cells
(Cotes et al., 2008). This intracellular and extracellular enzyme activity is necessary for
M tuberculosis to survive in its dormant state, and thus survive until the host immune
system is sufficiently weakened. Inhibition of enzymes critical to lipid metabolism is a
potential method being researched in this thesis as a cure for TB. Ultimately, this thesis
will examine the substrate specificity between a TB esterase and two designed substrates
that could potentially assist in esterase inhibition.
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Enzymes
Proteins that are used to increase the rate of a chemical reaction are called
enzymes. Enzymes act as catalysts, meaning that they speed up reactions without being
altered by the reaction; this unaltered structure allows for an enzyme to be reused again
and again during its lifespan (Nelson & Cox, 2008). Enzymes contain pockets called
active sites. These active sites bind one or more molecules, called substrates, which are
involved in the chemical reaction being accelerated. The enzyme uses substrate
-+
-t
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Substrates Our enzyme (blue)
among others
Figure l. Selection of the correct substrate based on the
best fit and chemical characteristics
positioning or conformation changes in
order to make a chemical reaction more
favorable and decrease its activation
~nergy (Nelson & Cox, 2008). Enzymes
tend to bind with some substrates more
than others due to highly favorable
conformation and binding interactions;
these substrates that bind well can
potentially have a high specificity for the enzyme. Specificity allows the enzymes to
preferably bind to certain substrates over those competing for the active site (Nelson &
Cox, 2008). Figure 1 shows substrates of several shapes and enzymes whose actives sites
differ in shape. The blue substrate and enzyme serve as a simplified example of how
corresponding shapes can allow for specificity between them. Figure 1, however,
oversimplifies the interaction between an enzyme and a substrate, as an enzyme-specific
substrate may not fit perfectly into the binding pocket initially (as is indicated by the
matching shapes in the figure), but may cause the enzyme to undergo a conformational
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change that favorable fits the substrate. The enzyme obtains its best substrate interaction
when it has an active site that conforms to the reaction transition state; this is the point at
which molecules have an equal chance of either returning to substrate or becoming
products (Nelson & Cox, 2008). The optimal interaction between an enzyme and its
transition state contributes to the specificity of a substrate to a particular enzyme.
By studying the mechanisms of enzyme-substrate reactions, the affinity between a
particular substrate and enzyme can be examined. The steady state rate at which the
enzyme initially converts substrate(s) into product(s) is called initial velocity (Vo); when
steadily higher concentrations of substrate are used against constant enzyme
concentrations, V0 increases until it reaches its maximum value, Vmax (Nelson & Cox,
2008). This phenomenon was examined by Leonor Michaelis and Maud Menten who
E+S
k2
-)100- E+P
developed an enzyme theory and the well-
k_1
known Michaelis-Menten equation
Figure 2.Michaelis -Men ten enzyme-substrate
reaction (Nelson & Cox 2008)
(Menten & Michaelis, 1913). Their
enzyme theory was based on the enzyme-
substrate reaction shown in Figure 2. Initially, the enzyme and substrate combine in a
reversible reaction at a combination rate of k. to become enzyme-substrate complex (ES)
with a corresponding degradation rate of k.i. The ES complex can then undergo a
chemical reaction that results in a separate enzyme and product (P) at a rate of k2.
Michaelis and Menten theorized that upon first combining the enzyme with abundant
substrate, the system exhibits steady-state behavior where product is created at a constant
rate and [ES] is constant; this initial steady-state behavior is represented by the Vo value
and is the basis for the Michaelis-Menten equation shown below (Nelson & Cox, 2008):
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Equation 1. Michaelis-Menten equation and Michaelis constant (Kill) definition
The Michaelis constant (Km) is commonly used as a measure of affinity between
the enzyme and the substrate, although its meaning can be changed based on the rate-
limiting steps of the catalysis. Another rate constant, called either the turnover rate or kcat,
was defined in order to represent rate limitations caused chemically by reactions at
saturation (Nelson & Cox, 2008). The kcat constant is calculated by dividing Vmax by the
total enzyme concentration, and it represents the number of substrate molecules that the
enzyme is able to convert to product during a certain period of time. Neither KM nor kca!
provide an appropriate rate measurement that accounts for all aspects of the reaction, so a
parameter, called the specificity constant (Equation 2), was developed in order to allow
for comparison of turnover between different substrates against the same enzyme.
k
Specificity Constant = catKm
Equation 2. Rate of conversion from E+S to E+P called the specificity constant
For the substrate comparisons being performed in this thesis, the specificity constant is
used as the main comparative measure between the substrates used in enzymatic testing.
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Lipases and Esterases
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M tuberculosis depends on the function of hydro lases in order to survive, grow,
and spread throughout a host body. Hydrolases are enzymes that are able to divide a
substrate into two separate molecules by hydrolysis. The enzyme breaks a chemical bond
in the substrate, replacing the two ends with either an alcohol group (-OH) or hydrogen (-
H). By creating smaller and smaller molecules via hydrolysis, hydro lases breakdown
Substl'1l!e
o
R,·O~"
Product I
R
P
H
intra- and extracellular host
lipids into useful energy for the
pathogen (Cotes et al., 2008).
Lipases and esterases are two
specific types of hydro lases that
are used for this critical lipid
metabolism within.!v!
tuberculosis.
o
~
0"
sJ,
Figure 3.Catal ytic mechanism of serine hydrolase. This A lipase's key function is to
mechanism is the same for both lipases and esterases in which an
acyl enzyme intermediate is involved in the hydrolytic cleavage break down lipids into fatty
that releases one of the cleaved products (Copied from Holmquist,
2000) acids and alcohols through the
Acyl enzyme
~.,
hydrolysis of an ester bond (Holmquist, 2000). Biologically, lipases function as a means
Product Z
to hydrolytically break down large lipids within an organism to provide energy and
materials for growth (Holmquist, 2000). In humans specifically, lipases are used within
adipocytes to break down triacylglycerols and cholesterol; these products are used to
maintain the energy balance in the body (Schicher et al., 2010).
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Esterases share many characteristics with lipases, including the hydrolysis of ester
bonds using the same protein fold (a/~- hydrolase protein fold), the same catalytic triad
(nucleophile-His-acid) to perform catalysis, and the assistance in lipid metabolism in
biological systems (Holmquist, 2000). The main difference between lipases and esterases
is that esterases prefer to cleave at ester bonds located on shorter substrates « 10 carbons)
whereas lipases normally cleave at ester bonds on longer substrates (> 10 carbons).
Acetylcholine esterase from Torpedo calif arnica (an electric ray) and butyrylcholine
esterase in humans are a couple of examples of biologically relevant esterases (Holmquist,
2000). In Figure 3, the mechanism of catalysis by serine hydrolase, an example of a
mechanism performed by either a lipase or an esterase, is shown. Serine hydrolase
exhibits the catalytic triad (nucleophile-His-acid) that is present in the a/~- hydrolase
family; for this enzyme, serine is the nucleophile and aspartate is the acid. The catalytic
triad is able to assist with hydrolysis by positioning the ester correctly; the hydrogen on
histidine hydrogen-bonds to an ester oxygen in the substrate while the double-bonded
ester oxygen donates electrons that allow for attachment to the serine group via the ester
carbon. This process forms a negatively charged tetrahedral transition state that is
stabilized by other nearby amino acids via the formation of an oxyanion hole (Holmquist,
2000). This transition state allows electrons to be redistributed within the nucleophile-
substrate complex such that the R-group on the initial ester substrate is removed; this
leaves an acyl enzyme intermediate with part of the original substrate still attached. The
addition of water releases a carboxylic acid derivative of the initial substrate, and returns
the enzyme back to its free state. Other enzymes in the a/~- hydrolase family perform
this catalysis mechanism using their own catalytic triads (Holmquist, 2000).
In TB, specific hydrolytic enzymes, including key metabolic lipases and esterases,
have been directly linked to the virulence of M tuberculosis (Singh et al., 2010). Their
key roles in the virulence of TB are tied to the ability of TB lipases and esterases to break
down host tissues and to utilize the products for energy and growth (Singh et al., 2010).
M tuberculosis also stores large quantities of lipids during the dormant phase; this
storage lipid can then be broken down by
hydrolytic enzymes upon cell reactivation in
order to provide the energy to multiply and
trigger an infection (Singh et al., 2010).
These enzymes also use lipids from host
membranes, causing destruction of host cells
and increased virulence (Cotes et al., 2008).
At least 250 enzymes have been found to be
involved in lipid metabolism processes
within M tuberculosis (Cole et al., 1998); of
these, 24 putative lipases have been identified
to assist in both survival during dormancy
r: ,Cap
domain
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Figure 4. Structure of RV0045c. The a/~ fold is shown in
dark blue and the cap domain is shown in purple. The
binding pocket is highlighted in green and red (Zheng,
2011). Image created in PyMOL (DeLano Scientific, LLC)
and host cell infection (Singh et al., 2010). A recent study showed that a lipase within the
cell wall of_Nf tuberculosis (RV3802c) has a negative effect on TB cell growth when its
catalytic activity is inhibited (West et al., 2011). Without the lipases and esterases used in
lipid metabolism, M tuberculosis would be unable to obtain useful energy during its
dormant phase, and would likely die within the body before the pathogen could become
virulent. Even if the organism was able to survive through dormancy, its ability to infect
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host cells would be greatly diminished without the hydrolytic enzymes responsible for
membrane breakdown.
For this thesis, substrate testing was performed using the TB hydrolase Rv0045c,
shown in Figure 4. Rv0445C is proposed to be responsible for ester and lipid metabolism
in M tuberculosis, and recently had its three-dimensional structure determined (Zheng,
2011). Rv0045c is pH and thermally stable under ranges that include physiological
conditions (PH 6.0 - 10 and less than 40°C respectively), allowing it to survive within
human host cells (Guo et al., 2010).
Rv0045c is currently
/
classified as an esterase, as it exhibits
higher enzymatic activity on shorter
esterase substrates (p-nitrophenyl
derivatives of2-8 carbon length). An
example of the binding of one of
these derivatives is shown in Figure 5.
Figure 5. Labeled binding site and active site of RV0045c The substrate p-nitrophenylcaproate
with p-nitrophenyl caproate bound. The binding site is
composed ofG90, Q92, Ll55, 1252, and F255, and the (six carbons in the hydrocarbon chain)
active site contains S 154 and H309. The p-
nitrophenylcaproate substrate is shown in green, red, and is bound within the active site, and its
blue colors (copied from Zheng et al., 20 II).
hydrocarbon chain is complementary
to the binding pocket. This indicates that the Rv0045c enzyme is most likely to act
specifically with short-chain esters, and based on sequence homology to known bacterial
esterases is likely an enzyme involved in the lipid metabolism of M tuberculosis (Zheng
et al., 2011). Structures in the p-nitrophenylcaproate substrate were considered when
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synthesized substrate design was being determined; the designs both incorporate a short
chain of comparable length to p-nitrophenylcaproate and one design contains a phenyl
group similar to those on all of the tested p-nitrophenyl derivatives. The details of the
chosen substrate designs are discussed later in the background section.
Fluorescence
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Fluorescence is the light that is emitted from an excited particle after it has
absorbed energy ("Fluorescence", 2012). The Jablonski Diagram in Figure 6 shows that
energy jumps from a base level, So, to a higher energy level, S2, upon excitation. The
energy of the excited S2level is then decreased by internal conversion or nonradiative
decay and then the remaining energy is released as
fluorescence until energy returns to So (Lavis &
Raines, 2008). This fluorescent radiation is often
within the visible light spectrum and can be
measured using spectroscopy. In addition,
fluorescence ceases almost immediately when the
Figure 6.Ja blonski Diagram showing the energy source responsible for its excitation is
energy levels of a photon in its excited state
(i), after its internal conversion (ii), and removed ("Fluorescence", 2012). These
during its fluorescence (iii). (copied from
Lavis & Raines, 2008). characteristics make fluorescence a valuable tool in
biological and chemical measurements in which observation and controlled variables are
crucial.
Fluorescence is found in natural biological settings. For instance, fluorescence has
been observed in a type of wood called Lignum nephriticum, in the chlorophyll found in
plants, in various types of fluorite crystals, and in the jellyfish Aequorea victoria (Valeur
& Berberan-Santos, 2011). Researchers have taken these observations and developed the
fluorescent molecules or fluorophores found in nature and new synthetic fluorophores for
laboratory use (Nelson & Cox, 2008).
Fluorescence is typically measured by
a fluorimeter that first stimulates a sample
with light (excitation) before recording the
emission spectra of the molecule in arbitrary
units (Jameson et al., 2003). This
measurement can create two types of
fluorescence spectra. The first is an emission
spectrum that maintains a steady excitation
wavelength and measures fluorescence intensity
against wavelength, as shown in Figure 7. The
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280 320 360 400 440
Wavelength (nm)
Figure 8. Examples of emission scans.
Fluorescence intensity peaks represent emission
scan of 50mM phosphate buffer at 270 nm (solid),
280 nm(dashed), and 290 nm (dotted) (copied from
Jameson et al., 2003)
second spectrum, an excitation spectrum, measures the fluorescence intensity at a
specified emission wavelength; this measure reveals which wavelength of light is most
efficient at exciting the molecule. A molecule's fluorescence can be used in a number of
biological and chemical experiments, including distance estimations and the
determination of subunits in a particular structure (Jameson et al., 2003). Fluorophores
such as anthracene for the indication of ions, quinolium for the presence of chloride ion,
and indole for sensing
+2R
~
calcium, have become
important tools for
researchers studying a
variety of biological signals
(Lavis & Raines, 2008).
Figure 7. Transition of fluorescein between its lactone and quinoid
state based on attachment ofR groups (copied from Lavis &, Raines,
2008) In this thesis, the
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fluorophore, fluorescein (Jameson et al., 2003), is used to create latent fluorogenic ester
substrates for fluorescence studies on enzyme-substrate interactions. Fluorescein is a near
perfect emitter in its standard quinoid form, but when it is substituted at its phenolic
oxygen, it undergoes a tautomerization to create the lactone form, which is
nonfluorescent (shown in Figure 8). In this thesis, an ester will be attached as the R-
groups on fluorescein to lock it in the nonfluorescent lactone form, then addition of an
esterase, such as RV0045C, will hydrolyze the ester, releasing the highly fluorescent
fluorescein (Lavis & Raines, 2008). Because the substrates are protected in the lactone
state and fluoresce only when acted upon by an enzyme, we call them latent fluorophores.
One way to create latent fluorophores is through the addition of acetyl groups to the
phenolic oxygens on fluorescein via an acylating agent; the resulting substrate is
fluorescein diacetate (Lavis et al., 2010). Although the creation of ester groups prevents
the fluorescence of this substrate, the overall stability of fluorescein diacetate is low; this
is caused by low pKa values that make the ester bonds more likely to break in aqueous
solution (Lavis et al., 2010). To prevent substrate breakdown in aqueous solution,
acetoxymethyl (AM) ethers are used to mask the ester group and significantly decrease
the rate of background hydrolysis (Lavis et al., 2010). The low background hydrolysis
allows the increase in fluorescence intensity over time to be only an indication of the
esterase's enzymatic activity (Lavis et al., 2010). The ability to quantify enzyme-
substrate kinetics using fluorescence measurements allows for reliable and easily
replicated experiments.
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Substrate Synthesis
For my research, I chose two new latent fluorophores to synthesize. These two
substrates were designed to examine the importance of substrate f1exibility to hydrolysis
by Rv0045c. Limited work on the
OH
substrate specificity of Rv0045c
OH
suggested that it preferentially
o o
hydrolyzed substrates with shorter
(a) (b)
Figure 9. The initial carboxylic acids: 2-phenylbutyric acid
(a) and 2-ethybutyric acid(b).
carbon chains « 10 carbons) (Guo
et al., 2010). The carboxylic acids
used to synthesize the fluorogenic substrates are 2-phenylbutyric acid (a) and 2-
ethylbutyric acid (b) (Figure 9). These acids contain nine carbons and six carbons,
respectively, and thus fit the previously established substrate criteria. These chains on
both carboxylic acids are completely composed of hydrocarbons because the Leucine155,
Ile252, and Phe255 in the active site, shown in Figure 5, are hydrophobic (Zheng et al.,
2011). The carbon ring in 2-phenylbutyric acid, Figure 9a, increases the steric property of
the substrate whereas the two ethyl groups in 2-ethylbutyric acid, Figure 9b, allow for
flexibility at the tertiary carbon. The comparison of substrate hydrolysis of these two
substrates by Rv0045c will allow a comparison of similar substrates with different steric
properties.
The synthetic method used to create the desired substrates was modeled after the
synthesis of Tian and colleagues (Tian et al., 2010). The synthetic method contains three
main steps (Figure lO): (l) chloromethylation of the carboxylic acid, (2) iodination via an
Sn2 reaction to replace the chlorine atom, and (3) the combination of the iodomethyl
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ester with fluorescein to produce the final product (Tian et al., 2010). The alkylation at
the carboxylic acid (Figure 10 i) was achieved using chloromethyl chlorosulfate, a
common chloromethylating agent (Power et al., 2004). The addition of the chloromethyl
group greatly increases the hydrolytic stability of the of this intermediate substrate and
the chlorine provides a good leaving group for the following step. The second step,
II ;-el
cl-lI-o
a
Figure 10 ii(l), in the synthesis
then replaces the chlorine atom
with an iodine atom and was
performed by a classic Sn2
reaction, known as the
Finkelstein reaction
(Finkelstein, 1910). In the
Finkelstein reaction, acetone is
used as the reaction solution
because the reactant sodium
Figure t O.Syn thetic schematic of substrate A, fluorescein
di(phenylbutyloxymethyl ether). Step one (i) chloromethylated the iodide is soluble in acetone, but
carboxylic acid, and steps two and three (ii I and ii2) allow
fluorescein to combine with the acyloxymethyl group (Tian et al., the product sodium chloride is
2010).
insoluble in acetone. Thus, as the reaction proceeds, the iodomethylated ester product
will remain in solution while the sodium chloride will precipitate out of solution and
(a) (\11
drive the reaction (Finkelstein, 1910). In the third and final synthetic step (Figure 10
ii(2)), the iodomethylated ester and fluorescein were combined in the presence of silver
o
oxide. Depending on the electrophile in the reaction, this reaction can produce
(ii)
C~'1 A,~oJl
monoalkylated, monoacylated, or hybrid monoalkylated and monoacylated fluorescein,
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where the dialkylated products are desired over the diacylated or hybrid products due to
their higher stability. The reaction conditions for this final step favored alkylation
because the combination of methyl iodide (iodide is in the iodomethylated ester) and
silver oxide is commonly used for N-methylation which attaches a methyl carbon to a
single-bonded oxygen (Hughes, 2009). A column purification of the final solution was
conducted such that the less polar acylated fluorescein could be separated from the more
polar alkylated fluorescein.
After purification, the
synthetic process
allowed for production
of two unique
substrates that could
be used for enzymatic
testing of the esterase
Rv0045c (Figure 11).
These substrate
products will hitherto
be referred to as
a
Subsu-me .H
Figure 1l.Final synthetic products: fluorescein di(phenylbutyloxymethyl ether),
Substrate A, and fluorescein di(ethylbutyloxmethyl ether), Substrate B.
Substrate A and Substrate B for simplification and clarity.
---~-----------~~-~--
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Treatment for Dormant Tuberculosis (TB)
The goal of this research was to synthesize two novel latent fluorophores, to
understand the substrate specifici:y of an essential TB esterase, and to use this
information to design potential inhibitors of Rv0045c. Because TB lipases and esterases
aid in survival during the dormant phase, eliminating these important enzymes could
either reduce the risk of developing active TB or eradicate M. tuberculosis completely
(Gurdyal et al., 2010). A potential treatment option for dormant TB is to use prodrugs.
Potential prodrugs would be substrate-antibiotic complexes connected together by an
ester bond to specifically target M tuberculosis. This ester bond would act as a
protecting group to the antibacterial, allowing it to only release upon hydrolysis by an
esterase that recognizes this protecting group. To design an effective prodrug, requires
significant information about substrates or protecting groups with high activity and
selectivity for Rv0045c. This thesis provides an initial step in understanding the
specificity and selectivity of Rv0045c. Results from this thesis can then be refined
through the synthesis of new substrates with potentially higher activity and specificity
until a novel treatment for dormant TB infections can be developed.
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Results and Discussion
The three synthetic steps described in the background and materials and methods
sections of this thesis were used to create two separate fluorophores, fluorescein
di(phenylbutyloxymethyl ether), Substrate A, and fluorescein di(ethylbutyloxmethyl
ether), Substrate B. The first step in the synthesis was to chloromethylate the carboxylic
acid starting material: 2_phenylbutyric acid (a) and 2-ethylbutyric acid (b) (Figure 9).
The product of this reaction then underwent the Finkelstein reaction in the second
synthetic step in order to substitute the chlorine ion with an iodine ion, creating an
iodomethylated ester product. The products from the first and second synthetic steps were
not characterized by liquid chromatography mass spectroscopy (LCMS) or proton NMR,
as the product of these reactions were immediately used in the next step in the synthesis.
The final synthetic step combined fluorescein with the iodomethylated ester in the
presence of silver oxide. In this work, acylation occurred when the phenolic oxygen
acted as a nucleophile to the electrophilic ester carbon in the iodomethylated ester
product. The attachment at this location caused the detachment of the iodomethylated
oxygen such that the final attachment contained no methylene carbon ester. Additionally,
alkylation occurred when phenolic oxygen on fluorescein acted as a nuc1eophile to the
electrophilic methylene carbon; the oxygen's electrons formed a bond with the carbon
and released the iodine atom. Since fluorescein contains two phenolic oxygens, it can
produce a diacylated, dialkylated, or hybrid monoacylated and monoalkylated product.
These three products are shown in Figure 12a and Figure 13a for Substrate A and
Substrate B, respectively. The synthesis also had the ability to produce monoacylated
24
and monoalkylated products in which only one of the phenolic oxygens on f1uorescein
was acylated or alkylated (Figure 12b, Figure l3b).
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Figure 12. Potential products of fluorescein di(phenylbutyloxymethyl ether), or Substrate A. Products with
two attachments (A) are diacylated (i), hybrid monoacylated and monoalkylated (ii), or dialkylated (iii).
Products with only one attachment (8) are either monoacylated 0) or monoalkylated (ii).
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Figure 13. Potential products of fluorescein di(ethylbutyloxymethyl ether), or Substrate B. Products with
two attachments (A) are diacylated (i), hybrid monoacylated and monoalkylated (ii), or dialkylated (iii).
Products with only one attachment (B) are either monoacylated (i) or monoalkylated (ii),
(i)
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To separate the desired dialkylated products (Substrate A and Substrate B) from
the other products, silica gel column chromatography was performed. A relatively
nonpolar solution (hexane, ethyl acetate, and dichloromethane in 7.5:0.5:2 ratio,
respectively) was used initially to elute the more nonpolar diacylated product and then
the mobile phase was changed to a more polar mixture (hexane, ethyl acetate, and
dichloromethane in 7: 1:2 ratio, respectively) to
elute the dialkylated form of the product, as it is
the most polar of the disubstituted products.
Movement of product through the column was
tracked using UV light and thin layer
chromatography (TLC). Once initial products
began to elute from the column, fractions (5mL)
were collected until all of the products were eluted.
TLC plates were spotted with each fraction to
determine which of the fractions contained the
desired product and the purity of the purified
fractions. Based on TLC results, only the fractions
that contained only one band were collected for
future analysis. An example of a TLC plate is
shown in Figure 14.
A B c
Figure 14. Example of a TLC plate. The strips
shows three tested fractions (A,B, and C) that have
produced three distinct bands. In the case of the
TLC performed in this thesis, the highest band (A)
is the most nonpolar and the lowest band (C) is the
least nonpolar. Of these fractions, only B would be
kept because its solution contains only one product.
Since the potential products all have slightly
different polarities, band separation was observable between them by TLC. Since the
solution used for TLC had a high ratio of hexane (nonpolar), the most nonpolar
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compounds traveled farther on the plate than the polar compounds. The desired
dialkylated product is the most polar of the disubstituted products, so it was expected to
elute last from the silica column and to be the lowest band observed on the TLC.
Products that were either monosubstituted or nonsubstituted are even more polar than the
dialkylated products; for this reason, it was assumed that these were left on the column
after band separation and that they would not be observed on the TLC plates.
Analysis of the TLC results indicated that the Substrate A reaction resulted in
three distinct products, and that the Substrate B reaction had four products. Fractions
from the silica gel column containing products of identical relative mobility on the TLC
were combined to create the samples used for product characterization. This
characterization utilized two laboratory tools to determine the chemical identity of the
collected products (described more later). The synthesis and column purification of
Substrate A provided three separate products, and the synthesis of Substrate B produced
four products.
The seven total products from substrate A and B were then characterized by liquid
chromatography mass spectrometry (LCMS) and proton nuclear magnetic resonance
spectroscopy (H NMR). The LCMS was conducted under positive ionization mode and
identified the molecular weights (MWs) of any parent ions in solution and their relative
concentrations. An observed MW close to the expected MW of the desired dialkylated
product was considered strong evidence that the correct product was synthesized. In
addition, H NMR spectroscopy was performed to determine if the proton signals matched
those that would be expected based on product predictions from the LCMS. Due to H
NMR contamination, the following peaks should be disregarded due to the contaminant
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solution they are known to represent: 7.26ppm (CDCL3, s), 5.30ppm (dichloromethane, s),
4.12ppm (ethyl acetate, q), and 2.17ppm (acetone) (Gottlieb, H. 1997). The figure
legends of each H NMR spectrum give peak integration details for those that are
significant in determining product structure.
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Figure 15. LCMS spectra of Substrate A, sample I. The MW for parent ions (left) and the MW frequency
of daughter fragments (right). The most frequent parent ion MW is 655.4 g/mol and the top three fragment
MWs are 333 g/rnol, 509.1 g/mo1, and 479.1 g/mol
...... ':'''~ '" ...•7- ,.~ _ ... ! ,.., "'"<: I~ ~"<); ..~:~ A,
j " ¥" d "", v:~.;. '';;
\ "'"~\\\ IMY
! "''''iJ 1(1"";'''''
"1' , ,-"',".',-."'•. ..,..."''''."'" • I ' ~~""'".'~'.;..,'.·'>·'.' .. '.W ..·,'I.,'.,.'''.-.·,'-· •.... "'I" ...... ~.,., ,,, I .-~
~ ," ,1 ~,tl»,\,
Figure 16. H NMR spectrum for Substrate A, sample 1. IH NMR (300MHz, CDCI3) 8 (ppm): 8.00 (d, IH),
7.60 (quin, 3H), 7.10 (d, 2H), 6.95 (d, 4H), 6.71 (ddddd, 4H), 3.68 (t, 2H), 2.20 (sep, 2H), 0,95 (d, 4H)
31
For Substrate A, the expected molecular weight of the desired dialkylated product
is 686.71 g/mol, and the MW of2-phenylbutyric acid (the carboxylic acid used in its
synthesis) is 164.2 g/mol. The LCMS spectra from the first sample from Substrate A are
shown in Figure 15. The MW of the parent ion in this solution is 655.4 g/mol; this is
approximately 30 g/molless than the desired product. This molecular weight corresponds
to the hybrid monoacylated and monoalkylated form of the product A, whose MW is
656.71 g/mol. The MW of the most abundant fragment, 333g/mol, corresponds to the
MW of a fluorescein molecule (332.31g/mol). The daughter ion with MW 509.1g/l110l is
likely the result of the original product losing a side chain due to cleavage at the ester
bond. If the MW of the side chain up to the ester bond (147 g/rnol) is subtracted from the
MW of the parent ion (655.4 g/mol), the weight of the expected molecule would be 508.4
g/mol. The MW 479.1 g/mol fragment is the result of the product losing the entire
alkylated attachment (176.2 g/mol), including the ester bond and the methylene carbon.
When the MW of the attachment is subtracted from the parent ion MW, the calculated
MW is 479.2 g/mol, which is close to the MW from the LCMS.
The figure legend of the H NMR spectrum in Figure 16 gives the locations of
prominent peaks. Those in the 6.5 to 8.5ppm range indicate the protons on the phenyl
groups in the R-group and the multiple aromatic rings in fluorescein, and the noisy
cluster of peaks in the 0.8 to l.5 ppm represent the alkane protons on the ethyl groups.
The triplet peak at 3.68 ppm is specific to the products of the substrate A synthesis; this
peak represents the proton on the tertiary carbon between the ethyl and phenyl groups on
the attachment. For the H NMR spectrum to indicate the presence of hybrid
monoacylated and monoalkylated product, a singlet, 2H peak should be seen at
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approximately 5.8ppm. This peak would indicate the presence of one methylene carbon.
This peak does not exist, though it may have shifted toward 5.4ppm where it could be
masked by the dichloromethane contaminant peak.
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Figure 17. LCMS spectra of Substrate A, sample 2. The MW for parent ions (left) and the MW frequency
of daughter fragments (right). The most frequent parent ion MW is 655.3 g/mol and the top three fragment
MWs are 332.9 g/mol, 509.1 g/mol, and 479.3 g/mol
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Figure 18. 1-1 NMR spectrum for Substrate A, sample 2. 11-1NMR (300MHz, CDCI3) 0 (ppm): 8.00 (d, 11-1),
7.63 (quin, 21-1),7.11 (d, 21-1), 6.97 (d, 11-1),6.68 (m, 51-1), 5.71 (s, 21-1),4.11 (q, 21-1),3.69 (t, IH), 3.47 (t,
IH), 2.15 (sep), 0.95 (d, 41-1)
The second sample from Substrate A (Figure 17) produced nearly identical results
to those from the first sample (Figure IS). Again, the data support that this sample is the
hybrid monoacylated and monoalkylated substrate product due to the parent ion MW
being 65S.3 g/mol, around 30 g/mollower than the expected MW. The MWs of the
daughter ions (332.9g/mol, S09.1g/mol, 479.3g/mol) are nearly identical to those from
the first sample (332.31g/mol, S09.1g/mol, 479. 1g/mol). They are again presumed to
represent the fluorescein molecule, the parent ion without the acylated attachment, and
the parent ion without the alkylated attachment, respectively.
The H NMR spectrum in Figure 18 shows aromatic and alkane proton peaks
similar to those from the first sample. The two triplets at 3.69ppm and 3.47 ppm
represent the tertiary carbon protons specific to this substrate. Unlike the first sample, a
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2H singlet peak exists at 5.71ppm, indicating the presence of one methylene carbon. The
LCMS spectra and the H NMR spectrum complement each other and strongly indicate
that this product is the hybrid monoacylated and monoalkylated substrate product.
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Figure 19. LCMS spectra of Substrate A, sample 3. The MW for parent ions (left) and the MW frequency
of daughter fragments (right). The most frequent parent ion MW is 655.4 g/mol and the top three fragment
MWs are 332.9 g/mol, 509.1 g/mol, and 479.1 g/mol
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Figure 20. H NMR spectrum for Substrate A, sample 3. lH NMR (300MHz, CDCI3) 8 (ppm): 8.03 (d, IH),
7.65 (quin, 2H), 7.13 (d, 2H), 6.78 (d, 2H), 6.61 (g, 4H), 5.73 (d, 4H), 4.11 (g, 2H), 3.48 (t, 2H), 2.10 (sep,
6H), 1.95-1.45 (m, 10H), 0.95 (d, 6H)
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Identical to samples 1 and 2 from substrate A, sample 3 from substrate A gave a
parent ion MW, which indicated that the synthesis produced the hybrid monoacylated and
monoalkylated substrate product. Figure 19 shows that the parent ion MW was once
("'o",,-,~,,,"""""" , ~.",~ , , ..• "-'~~"r',•.~ , •. "". "'1'''-','-''''-¥ "'-~"., j'" y_'~ "~'" "'''1'' ..-.-,,-~'.•.•".,':-.- ,. ': •.~",,".•,-,..,.• "1''''-~ ,- y .. "··..1-- . '.',' ,.-."•..•-r--: y-y .'.' "V • ~ .. '. ,'-"'~'" .. • .. l·-· ..
!.1 ::..0 ') t) ( "1 H'~
j! I; III
''''I 1>:1 1"1
1"1 I· 1"1r: 1';1
,
[iI>, I:! 11
again 655.4 g/mol, and 30 g/molless than the expected MW of Substrate A. The three
most frequent daughter fragment MWs (332.9g/mol, 509.1g/mol, 479.1g/mol) are nearly
identical to those for the first and second samples; these MWs represent fluorescein, the
parent ion without its acylated attachment, and the parent ion without its alkylated
attachments, respectively.
Figure 20 shows a doublet peak with 4H in this vicinity (5.73ppm); although it appears in
the correct location, this peak does not represent the methylene carbon ether because (1)
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the double peak indicates the presence of adjacent hydrogen and (2) the 4H indicates that
this occurs in two locations rather than one. In addition, the S.73ppm peak in the third
sample does not match the peak that would be indicative of the desired dialkylated
product; if it were, there would only be a singlet peak since the methylene carbon ether
has no adjacent hydrogen.
From the LCMS spectra of the three Substrate A samples, all three Substrate A
samples appear to be the hybrid monoacylated and monoalkylated form of the desired
product. All of the sample H NMR spectra (Figures 16, 18, and 20) also show nearly
identical results in the aromatic region (6.S-8.Sppm). Only samples 2 and 3 show the
unique feature of an alkylated product, which is a 2H peak at approximately S.8ppm,
indicating the presence of the methylene carbon in the ether (Figure 17). Proper
identification by NMR is also complicated by the presence of a doublet peak with 4H in
this vicinity (S.73ppm) for sample (Figure 21). This splitting pattern would not be
expected for the methylene carbon, which would be a sinzlet even in the dialkylatedto ,
form. Based on this analysis, two items can be confirmed: (1) only the second sample can
confidently be labeled as hybrid monoacylated and monoalkylated substrate product and
(2) none of the samples are the desired dialkylated Substrate A. The nearly identical and
undesired synthesis results from these three samples suggest one of two things: either the
synthesis did not produce any of the desired substrate product or the purification in the
column was halted before the desired substrate had come off of the column. As
explained previously, the desired substrate is the most polar of the possible products and
would have been collected from the column last; ending the purification too early would
have missed the collection of the desired dialkylated product.
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Substrate B
The expected MW of Substrate B is 590.63 g/mol, and 2-ethylbutyric acid, the
carboxylic acid used to create the substrate, has a MW of 116.16 g/mol.
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Figure 21. LCMS spectra of Substrate B, sample 1. The MW for parent ions (left) and the MW frequency
of daughter fragments (right). The most frequent parent ion MW is 531.3 g/mol and the only fragment
MWs is 453.1 g/mol.
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Figure 22. H NMR spectrum for Substrate B, sample I. IH NMR (300MHz, CDCI3) i5 (ppm): 5.60 (s, 1H),
4.89 (s, IH), 3.42 (q, 2H), 1.98 (s, 2H), 1.57 (s, 10H), 1.15 (quin, 32H), 0.95 (d, 2H)
For substrate B sample 1, the highest frequency MW of a parent ion was 531.3
g/mol (Figure 21). This MW is approximately 60 g/molless than the expected MW for
Substrate B. This MW indicates that substrate B sample 1 is the diacylated form of
Substrate B, as the removal of two methylene carbon ether groups gives an expected MW
of 530.63 g/mol (2C + 41-1+ 20). The fragment MW, 453.1 g/mol, is likely the
fluorescein molecule with only one acylated attachment to it. Fluorescein has a MW of
332.31 g/mol and the acylated attachment (no methylene carbon ether) has a MW of
116.16 g/mol. When these are added, the sum is 448.47 g/mol; this total is close to 453.1
g/mol of the fragment.
The H NMR spectrum in Figure 22 expectedly shows proton peaks mostly on the
lower, right side. The peak representing the proton at the tertiary carbon between the
I~
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ethyl groups can be distinguished as the quadruplet 2H peak at 3.42ppm. The other
alkane protons are likely combined into the peaks at 1.S7ppm and 1.lSppm in an
indistinguishable pattern. The presence of the singlet, 1H peak at S .6ppm does not likely
indicate a methylene carbon proton since this feature would only be indicated by a 2H
peak. Both the LCMS spectra and H NMR spectrum complement each other to show that
the first sample is the diacylated substrate product.
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Figure 23. LCMS spectra of Substrate B, sample 2. The MW for parent ions (left) and the MW fr~quency
of daughter fragments (right). The most frequent parent ion MW is 589.4 g/mol and the top three fragment
MWs are 332.1 g/mol, 451.1 g/mol, and 431 g/mol.
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Figure 24. H NMR spectrum for Substrate B, sample 2. 1H NMR (300Ml-lz, CDC]3) 8 (ppm): 5.60 (s, 11-1),
4.89 (s, IH), 3.42 (g, 8H), 1.98 (s, 4H), 1.60 (s, 10H), 1.19 (quin, 32H), 0.90 (d, 21-1)
The LCMS spectra from sample 2 of Substrate B (Figure 23) suggest that it is the
dialkylated substrate. The parent ion MW most detected in this solution was 589.4 g/mol
and is very close to the expected MW of 590.63 g/mol. The daughter fragment MW of
332.9 g/mol represents the fluorescein molecule by itself (MW 332.31) and the fragment
MW of 451.1 g/mollikely represents the dialkylated substrate with one alkylated
attachment removed. When the MW of the alkylated attachment is subtracted from the
parent ion MW (589.4 g/mol - 129.16 g/mol), the total difference of 460.2 g/mol is
somewhat close to the observed fragment MW. The other fragment MW, 431 g/mol, is
not easily explained because a leaving group of about 20 g/mol is not readily seen on the
monoalkylated substrate of MW 451.1 g/mol.
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The H NMR of this sample tells a different story (Figure 24). The dialkylated
substrate is expected to show a singlet 4H peak at approximately S.8ppm. Although a
peak exists in this location, it is only a IH peak, indicating that there is not methylene
carbon ether in this product. If this sample is actually diacylated product, the extra MW
shown in the LC cannot be readily explained by the H NMR. The alkane proton peaks
between O.9ppm and 1.6ppm are likely to still represent the alkane protons on the two
ethyl groups in the f1uorescein attachment. Because the peaks are noisy in this region, it
is difficult to distinguish any major differences between these peaks and those for the first
substrate. These results are inconclusive as to the identity of the second sample.
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Figure 25. LCMS spectra of Substrate B, sample 3. The MW for parent ions (left) and the MW frequency
of daughter fragments (right). The most frequent parent ion MW is 589.3 g/mol and the top three fragment
MWs are 332.9 g/mol, 461.1 g/mol, and 559.1 g/mol.
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Figure 26. H NMR spectrum for Substrate B, sample 3. IH NMR (300MHz, CDCI3) I) (ppm): 8.01 (d,2H),
7.66 (ddd, IH), 7.16 (d, lH), 6.97 (s, IH), 6.81-6.71 (m, 2H), 5.81 (s, 4H), 5.66 (s, IH), 5.39 (5, 2H), 5.23
(s, IH), 4.95 (s, lH), 3.48 (q, IH), 2.25 (s, 2H), 2.0 I (s, 18H), 1.75 (s, 12H), 1.58 (sex, 12H), 1.35-1.16 (m,
38H), 0.97 (d, 5H), 0.93-0.80 (m, 24H).
The third sample from Substrate B provided results that best exemplified those of
the desired substrate (Figure 25). As was the case in the second sample, the overall MW
of 589.3 g/mol was very close the expected MW of 590.63. The MWs of the fragments
were representative of fragments that could be released from the desired substrate. The
fragment of MW 332.9 g/mol is representative of fluorescein by itself, and this fragment
also appeared in the second sample. The fragment with MW 461 g/mol is indicative of
the fluorescein with one alkylated attachment. If the MW of the carboxylic acid (116.16
g/mol) and the MW of the methylene carbon (14 g/mol) are subtracted from the MW of
the expected substrate (590.63 g/mol), the difference is 460.47 g/mol; this is very close to
the fragment's MW of 461 g/mol. The final fragment ofMW 559.1 g/mol is
approximately 30 g/molless than the expected MW of Substrate B; this likely indicates a
product fragment in which one ethyl group (29 g/mol) was removed. Based on the
LCMS results, sample 3 from Substrate B was identified as the desired dialkylated
product.
As with the other two samples, the H NMR spectrum shows noisy, combined
proton peaks in the O.8ppm to 1.9ppm range (Figure 26). This sample's H NMR is
different because it had a singlet 4H peak at 5.81ppm, indicating the presence of two
methylene carbons. This data, in combination with the MWs from the LC spectra,
provide confidence that the third sample is dialkylated Substrate B.
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Figure 27. LCMS spectra of Substrate B, sample 4, The MW for parent ions (left) and the MW frequency
of daughter fragments (right). The most frequent parent ion MW is 655.3 g/mol and the top three fragment
MWs are 333 g/mol, 555.3 g/mol, and 509.1 g/mol.
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Figure 28. H NMR spectrum for Substrate B, sample 4. IH NMR (300MHz, CDCI3) i5 (ppm): 5.66 (5, 1H),
5.39 (s, 2H), 5.23 (s, lH), 4.95 (s, IH), 3.48 (q, 8H), 2.25 (s, IH), 2.09 (s, lH), 1.92 (s, IH), 1.73 (s, 5H),
1.58 (sex, 12H), 1.2 (t,12H).
The MW of the most frequent parent ion in the fourth sample (Figure 27) is 655.3
g/mol. This is approximately 60 g/mol greater than the expected MW of Substrate B. It
is proposed that this additional mass is caused by the addition of two extra methylene
carbon ethers (30 g/ml each). If these are added to the expected MW of the substrate, the
total MW is 650.63 g/mol and is very similar to the 655.3 MW obtained from the LCMS
spectra. This is logical because this sample was the last to be removed from the column
during separation and was therefore the more polar product obtained; additional ethers
increase the overall polarity of the molecule, and this is assumed to be the cause of this
observed polarity increase. Clearly, this is not the desired substrate due to this high MW.
The H NMR spectra in Figure 28 also support the determination that the product
in this sample contains additional methylene carbon ethers. The peaks at 5.66ppm,
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5.39ppm, 5.23ppm, and 4.95ppm could all indicate the presence of methylene carbon
ether. These total to 5H, and the presence of four methylene carbon ethers should be
represented by 8H. There is the possibility that the remaining 3H could be in a fifth peak
that is obscured by the dichloromethane contaminant peak at 5.4ppm. Upon combining
the results from the LCMS spectra and the H NMR spectrum, it is evident that this
product is not the desired substrate.
Based on all of the data from the Substrate B samples, the third sample was
determined to be the correct dialkylated product. Its LCMS spectra in Figure 25 clearly
showed the expected MW and feasible daughter fragments. The H NMR spectra from the
four samples of Substrate B ( Figures 22, 24, 26, and 28) exhibited similar behavior with
key differences at the location where a methylene carbon ether would be located. As
with the H NMR analysis for the Substrate A samples, desired dialkylated products are
expected to show a singlet, 4H peak at approximately 5.8ppm. The only spectra that fits
these criteria is for Substrate A sample 3. This nicely complements the data from the
LCMS spectra analysis. Although the true identities of the second and fourth samples are
unknown, an assertion can still be made that the third sample is the dialkylated Substrate
B. Since this is the only sample between the two sets of synthetic products that has been
identified as one of the substrates of interest, it is the only one that can be confidently
used in enzymatic kinetics experiments.
Enzymatic Kinetics
Upon identification of substrate B by
LCMS and H NMR spectroscopy, three
functional assays were performed. These
assays exposed the substrate to one of two
enzymes in the lab. During these tests, the
esterase would cleave the substrate at its ester
bonds, forming two carboxylic acids and a
f1uorescein molecule in its fluorescent state.
This is shown in Figure 29 in which substrate B
interacts with Rv0045c to produce a fluorescein
molecule and 2-ethylbutyric acid. The increase
in fluorescence upon ester hydrolysis of
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Figure 29. Hydrolysis of esters within tluorogenic
substrate. Schematic of the cleavage at the ester
bonds in substrate B caused by RV0045c. Products
include fluorescein (in its fluorescent state) and 2-
ethylbutyric acid.
Substrate B was monitored over time. Each enzyme assay utilized a 96 well microplate to
test eight substrate concentrations ranging from 0.05 uM to 1OO~lMin 1:2 dilutions. Initial
velocities for fluorophore hydrolysis were measured in triplicate to determine the error
for the measurement. As f1uorescence is proportional to the concentration of cleaved
substrate, a f1uorescein standard curve was used for each assay to convert t1uorescence
change over time into concentration change over time.
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Figure 30. Michaelis-Menten plot ofInitial PLE velocity versus [Substrate BJ. Data from substrate B
hydrolysis by pig liver esterase (PLE) is shown in blue dots, and the trendline generated in the Origin 6.1
program through a fit against the hyperbolic Michaelis-Menten equation is shown in black. The generation
of this trendline provided best fit values for Vmax and Kill'
To show that Substrate B behaved like a latent fluorophore, the background
hydrolysis rate and enzymatic hydrolysis rates were compared. The rate of background
substrate hydrolysis was minimal and Substrate B is highly stable in solution (data not
shown). This stability in solution is related to the presence of the methyl ether with its
increased pKa. In the presence of pig liver esterase (PLE), a conunon, general esterase,
Substrate B showed a rapid increase in fluorescence that scaled with concentration and
the results could be fitted to the Michaelis-Menten equation (Figure 30; Table 1).
Together these results confirm that Substrate B has the properties of an alkylated latent
f1uorophore with low background hydrolysis but rapid hydrolysis in the presence of an
esterase.
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Figure 31. Michaelis-Menten plot of Initial Rv0045c velocity versus [Substrate B). Data from substrate B
hydrolysis by the enzyme of interest, Rv0045c, is shown in blue dots, and the trendline generated in the
Origin 6.1 program through a fit against the hyperbolic Michaelis-Menten equation is shown in black. The
generation of this trendline provided best fit values for VllIax and Kill.
Now that the chemical identity and latent fluorophore properties of Substrate B
were confirmed, the substrate was tested for activity against Rv0045c (Figure 31).
Although the initial velocity for the hydrolysis of Substrate B by Rv0045c was not as
high as for the hydrolysis by PLE, significant hydrolysis was still observed. To get a
quantitative grasp on the differences between the enzymatic behavior of Rv0045c and
PLE enzymes, Origin 6.1 computer software was used to fit the data from the assays to
the Michaelis-Menten equation (Equation 1, background). This data fit calculated the
Vmax and Krn for each of the tested enzymes; keatand specificity constant values were
determined by using these obtained values with the Michaelis-Menten equations provided
in the Background portion of this thesis (Equation 1, Equation 2). All Michaelis-Menten
kinetic values are shown in Table 1.
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Table 1. Michaelis-Menten kinetic values based upon curve fitting of initial velocity data
PLE RvOO45c
Vmax(nMls) 0.05 ± 0,003 0,004 ± 0.0005
Km.(IlM) 53.5 ± 706 5.5± 1.6
kcat (5.1) 0.001 ± 6.9 X 10·~' 16 X 10-5:!: 2.1 X 10-6
kcat/Km (5·" rill") 20.99 2.95
PLE has a Vmaxof 0.05 nM/s, which is approximately ten times greater than the
Vmaxof Rv0045c at 0.004 nM/s. These relatively lower rates of hydrolysis by Rv0045c
suggests that Substrate B is not highly specific for the substrate binding pocket of
Rv0045c and only interacts weakly with the binding pocket of Rv0045c. When
comparing the Kmvalues for the two enzymes, the lower Killvalue for Rv0045c indicates
that the substrate binds better to Rv0045c than it does to PLE. This lower Kmvalue
indicates that a lower concentration of substrate is needed to obtain half of the enzyme's
maximum velocity. Although this is the case, the kcatvalue, which represents the
turnover rate, is much lower for Rv0045c than PLE. The determining factor of which of
the two enzymes was more specific to substrate B was the specificity constant (kcatlKrn)
since it weighed the kcatand Kmvalues against one another. Because the kcatvalue of
Rv0045c was so much less than that ofPLE, the specificity constant was higher for PLE
than for Rv0045c. Since PLE is a common enzyme and substrate B has a lower
specificity constant for Rv0045c than for PLE, it can be concluded that the substrate is
currently far from specific for this TB lipase; it may, however, represent a potential
starting point for future prodrug developments. The characterization of Rv0045c should
also be repeated before making any firm conclusions about its specificity to the substrate.
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Conclusion
In order to examine whether Rv0045c would show specificity toward either steric
or t1exible substrates, two latent fluorophores were created with unique acetoxymethyl
ether attachments. Upon completion of the synthetic steps necessary for their creation,
only one desired t1exible substrate, fluorescein di(ethylbutyloxymethyl ether), was
successfully identified via liquid chromatography mass spectrometry and NMR
spectroscopy. Enzymatic and background hydrolysis tests showed that the substrate
displayed very little specificity to the Rv0045c enzyme. Comparisons between steric and
t1exible substrate specificity cannot be made until a successful synthesis of the desired
steric substrate, di(phenylbutyloxymethyl ether), or some other steric substrate can be
accomplished.
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Future Directions
To accomplish the initial purpose of this thesis research, it would be necessary to
perform the synthesis of the steric substrate once more. Upon completion of the repeated
synthesis of this substrate, the column chromatography would be conducted using a more
nonpolar solvent to slow the movement of synthesized products through the column and
increase the separation between them. This work would additionally benefit from further
research into the specificity of the flexible substrate that was successfully synthesized.
This substrate should be tested on other bacterial esterases from the causative agents of
cholera, tularemia, and others in order to gain a better understanding of its relative
specificity to Rv0045c in M tuberculosis.
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Materials and Methods
Materials
All chemical reagents used for the syntheses and experiments in this thesis were
purchased from Sigma Aldrich and chosen based on the highest grade necessary for the
purposes of this research. Pig liver esterase (PLE) used in substrate testing was from
Sigma, and Rv0045c (esterase from Mycobacterium tuberculosis) was purified using the
previously published procedure (Guo et al., 20 10). Phosphate buffered saline buffer
(PBS) pH 7.4 was made using 8g NaCI, 1.44g Na2HP04, 0.27g KH2P04, 0.2g KCl.
Selection of Substrates
The synthesis of two fluorogenic enzyme substrates were attempted using
identical methods; these two substrates differed only in the carboxylic acid that was
chosen for the initial synthesis step. The two carboxylic acids chosen were 2-
phenyl butyric acid and 2-ethylbutyric acid and the major expected difference between the
two products was their inherent flexibility (Figure 31 (a) and (d»). 2-ethylbutyric acid is
likely highly flexible due to its two unconstrained ethyl chains off of a tertiary carbon; 2-
phenyl butyric acid contains one ethyl chain and one benzene ring connected to a tertiary
carbon, thus causing the acid to be bulky and comparatively more sterically hindered than
2-ethylbutyric acid. Although bulky, each of these carboxylic acids is fairly short in
comparison to standard long lipid chains, making them good candidates as substrates for
the esterases used in this research. The following procedure details the general synthetic
methods used to synthesis both fluorogenic enzyme substrates (fluorescein
di(phenylbutyloxymethyI) ether and fluorescein di(ethylbutyloxymethyl ether), Figure 31
S3
Cc) and (f), respectively) using the term 'carboxylic acid' in place of 2-phenylbutyric acid
and 2-ethylbutyric acid.
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Figure 32. Fluorogenic Substrate Synthesis of (A.) fluorescein di(phenylbutyloxymethyl ether) and (B)
fluorescein dieethylbutyloxymethyl ether). Each synthesis has two main steps, (i) methyl chlorination and
(ii) fluorescein alkylation.
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Synthesis of chloromethylated acid products (Figure 31, i)
Initially, a solution of chloromethyl chlorosulfate (600mg, 2.43mmol, 1eq) and
carboxylic acid (a) or (d) (1.5 eq) in 5 mL dichloromethane (CH2Ch) was added to a
solution of tetrabutylammonium hydrogensulfate (82.Smg, 0.1 eq) and K2C03 (l.34Sg, 4
eq) in 10mL DI water and 10 mL CH2Ch. This mixture was allowed to stir for 12 hours
at room temperature and was then placed in the freezer for storage. This overnight
synthesis theoretically produced the choromethylated version of each carboxylic acid: 2-
phenylbutyric chloromethylester (Figure 31A, b) and 2-ethylbutyric chlorornethylester
(Figure 31B, e). This resulting colloidal mixture was poured into a separatory funnel and
the organic layer (CH2Cb) was immediately removed and saved. Two additional
extractions of the aqueous layer were performed using CH2Ch (2 x IS mL). The
combined organic layer was then washed with saturated NaCI solution (30mL) and dried
using MgS04. Filtration through silica gel was used to remove all particulates from the
solution, and condensation was performed by rotary evaporation. This concentrated
product was the resulting chloromethyl ester shown in Figure 31, (b) and (e) and
concluded the initial step of the substrate synthesis (step (i) in Figure 31).
Synthesis offluorogenic enzyme substrate
The concentrated chloromethyl ester product was diluted in S mL acetone and
mixed overnight with NaI (361mg, 2.41mmol) as shown in Figure 31 A(ii)-l and B(ii)-l;
this reaction was used to substitute the chlorine atom with an iodine atom and form an
insoluble NaCI precipitate (Finkelstein, 1910). The resulting NaCI precipitate was
removed by filtering the product through cotton loaded into a glass pipet in which
pressure was occasionally applied. Excess acetone was applied to the solution as a wash
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in order to ensure all product was collected, and the filtered iodomethyl ether product was
concentrated used the rotovap. The concentrated iodinated ester was taken up in 2 x 2mL
additions of acetonitrile. After being transferred to a scintillation tube, fluorescein
(200mg, 0.602 mmol), 4-A molecular sieves (200mg) and anhydrous Ag20 (348mg, 1.5
mmol) were added; this mixture was stirred for 7 days at room temperature to complete
the substrate synthesis. The substrate solution was diluted with 100mL CI-bCb and
vacuum filtered through a layer of Celite to remove all particulates. The filtered product
was concentrated using the rotovap.
Column chromatography
To separate the correctly dialkylated fluorogenic substrate from other reaction
products (diacylated and monoacylated-monoalkylated), silica gel column
chromatography was performed. TLC plates were used to investigate the relative polarity
of each potential product and determine an appropriate solution ratio of hexane, ethyl
acetate, and dichloromethane to separate them via column chromatography. An RF value
between 15 and 20% was desired such that products with slight differences in polarity
could be separated from one another; this precaution prevented all of the products from
coming off of the column together in a highly polar solution. Five solutions (10mL each)
of differing hexane:ethyl acetate:dichloromethane ratios were created and used on
substrate-dotted TLC strips as follows: 8:0:2, 7: 1:2, 6:2:2, 5:3:2, and 5: 1:4. The least
polar solution (8:0:2) showed almost no band movement, and the slightly more polor
solution (7: 1:2) provided RF values around 20% for both substrates. The other three
solutions had RF values between 50-90% and were thus eliminated from consideration as
a column chromatography solution. Celite (3g) and substrate were put into CH2(]2.
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solution. Celite, being a porous powder, absorbed the substrate solution, and took up the
product before CH2Cb was removed by vacuum in the rotovap. At this point, the Celite
not only acted as a convenient way to transfer the substrate as a powder (rather than oily
concentrated solution), but it also acted as a solid particulate filter within the column.
Columns were prepared using an amount of silica gel equal to one-tenth of the substrate's
molecular weight (c: 68.67g, f: 59.06g) and enough sand to create a 2 inch layer above
the substrate powder. The initial column solution was composed of 8:0:2 solution to
keep from early flow through the column. After 300 mL of this solution was run through
the column, the solution was switched to a 7:0.5: l.5 ratio; this made the solution slightly
more polar to allow the potential products to move down the column. Product bands
could be seen using a UV light that detected the f1uorophore substrate component; once
clear product band separation was seen using this method, polarity was again increased
slightly to a 7: 1:2 solution in order to speed product movement through the column. Once
the UV light detected product bands within an inch of the bottom of the column, samples
were collected until all bands had passed through. Synthesis A (Figure 1A) produced four
product bands off of the column and synthesis B (Figure 1B) produced three product
bands. Each substrate purification produced about 60, 5 mL fractions.
Chemical characterization offinal synthetic products
The fractions collected from the column chromatography were initially analyzed
by TLC. Every third fraction was tested in a 7:0.5:l.5 TLC solution in order to determine
which of the fractions contained products. Because the solution was slightly polar,
fractions containing more than one product showed two separate product bands on the
plate. UV light allowed for these bands to be seen, and a heat gun was used to find bands
-
with denatured product (heat would cause these bands to turn pale yellow). After
performing initial TLC testing on one third of the fractions, the untested fractions
surrounding tested, product-containing fractions were then run on a TLC strip; this
prevented the testing of all sixty fractions if it was unnecessary. Three types of products
were expected with slightly different polarities: di-alkylated fluorescein (least polar),
mono-alkylated mono-acylated fluorescein, and di-acylated fluorescein (most polar) .. The
desired product, di-alkylated fluorescein, was expected to be one of the last, least-polar
detected bands in the collected fractions. Fractions containing identical, singular bands
on the TLC strips were pooled together and then characterized by H NMR and LCMS
with substrates put into deuterated chloroform and acetonitrile, respectively, to determine
which band was the desired di-alkylated substrate. The LCMS analysis was performed on
a triple quadripole. Solution was injected to the machine at a steady rate using a syringe.
Liquid chromatography was used initially within the machine to separate molecules
within the solution by polarity. Mass spectrometry was performed within the triple
quadripole to determine the MW of the parent ion; the MW is based on the mass to
charge ration (m/z) that is determined by the molecule's travel time. Finally, another
mass spectrometry was performed in which the parent ion was split into fractions by
argon; this allowed for the determination of daughter ion MW. Test results from H NMR
and LCMS analysis are shown in detail in the Results and Discussion section.
Fluorescence testing against PLE and Rv0045c
Using the mass of each substrate of interest, dimethylsulfoxide solvent was added
to each to create either a 10mM or 100mM solution. Using a fluorometer, PBS solution
was used as a control solution in emission and excitation scans from 300 to 600 11111. The
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substrate solutions were subjected to a 1:200,000 dilution in PBS, and emISSIOnand
excitation scans were performed with the emission maximum set at 520nmand the
excitation maximum set at 494nm. Pig liver esterase (PLE) was added in 10uL
increments until increased activity levels were observed. Additional scans were
performed on PLE diluted in PBS solution to ensure that the increased activity was
substrate-dependent.
Kinetic testing against PLE and Rv0045c
Three functional assays were performed In which t1uorescence due to ester
hydrolysis was monitored over time. A 96 well microplate was utilized to create and test
eight substrate concentrations ranging from 0.051lM to 100~lM in 1:2 dilutions in PBS
(150 ug/ml.) + BSA (0.1 mg/mL) at pH 7. To the substrate dilutions, an esterase (51lL of
150 ug/rnl.) was added for the PLE and Rv0045c functional assays, and PBS buffer was
added for the background substrate hydrolysis assay. Immediately after the addition of
enzyme, the microplate was placed into the fluorescent plate reader. The fluorescent
plate reader was set to measure fluorescence every 15 seconds for four minutes at an
excitation wavelength of 485nM and an emission wavelength of 520nm. A fluorescence
standard solution was prepared for each assay by creating eight known f1uorescein
solutions with concentrations ranging from 2.3nM to 300 nM in 1:1 dilution in PBS
buffer. From this data, a t1uorescein standard curve was made, which converted
fluorescence into the concentration of cleaved substrate. Initial velocity (Vo) values were
calculated by determining the slope of the cleaved substrate concentration against time
for each substrate concentration. Initial velocities were averaged over the triplicate
substrate measurements to account for error. Using the Origin software program, the
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initial velocities and substrate concentrations were fitted to a Michaelis-Menten curve,
and the Vmax and Km values and error measurements were recorded.
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